EN
HI
Windlas Biotech share price chart
Windlas Biotech Share Key Metrics
Volume
1.57 L
Market Cap
1846.32 CR
LTQ@LTP
2@894.70
ATP
918.33
Var Margin
19.58 %
Circuit Range
754.5-1131.7
Delivery %
12.18 %
Value
14.45 CR
ASM/GSM
No
Market Lot
1
Summary
WINDLAS stock price is ₹894.7 as of 12 Aug, 2026. The stock intraday movement has stayed between ₹887.30 and ₹957.60, while Windlas Biotech share price 52 week high low is ₹697.40 & ₹1097.90.
In terms of trading activity, WINDLAS share price has recorded a volume of 1,57,341 shares. The Windlas Biotech has a market cap of ₹20636229. The stock’s Average Traded Price (ATP) stands at ₹918.33, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹894.70.
The Windlas Biotech upper circuit limit is ₹1131.70 & The Windlas Biotech lower circuit limit is ₹754.50, with a Value of ₹14.45 CR. The Delivery Percentage for the day is 12.18%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Windlas Biotech Fundamentals
P/E Ratio
29.29
P/B Ratio
3.79
Div. Yield
0.67
Sector P/E
65.02
Sector P/B
3.32
Sec. Div. Yield
0.51
Windlas Biotech Resistance and Support
Pivot 904.38
Resistance
First Resistance
1000.71
Second Resistance
1058.33
Third Resistance
1154.66
Support
First Support
846.76
Second Support
750.43
Third Support
692.81
Windlas Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 12 2026 | 944.9 | 894.7 | -5.13% | 957.6 | 887.3 |
| Tue Aug 11 2026 | 839.79 | 943.09 | 12.32% | 962 | 808.04 |
| Mon Aug 10 2026 | 882.84 | 839.65 | -4.89% | 894.5 | 820.5 |
Windlas Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-21 | Audited Results & Final Dividend |
| 2026-04-17 | Buy Back of Shares |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Windlas Biotech News
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Windlas Biotech delivered strong Q1 FY27 results with revenue climbing 18% YoY to Rs 248 crore. Adjusted PAT surged 37% YoY to Rs 25 crore, reflecting robust operational performance.
Aug 10 2026 16:15:58
Windlas Biotech Ltd - 543329 - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 10, 2026
Windlas Biotech reported Q1 FY27 revenue of ₹248.10 crore (up 18.09% YoY) and net profit of ₹17.65 crore. The company completed a ₹47 crore share buyback and approved a ₹6.30 per share dividend for FY26, also dissolving its US subsidiary, Windlas Inc.
Aug 10 2026 15:23:02
Windlas Biotech Management
| Name | Position |
|---|---|
| Ananta Narayan Panda | Company Secretary & Compliance Officer |
| Ashok Kumar Windlass | Whole Time Director |
Windlas Biotech Similar Stocks
Sakar Healthcare Ltd.
935.80
-17.95 (1.88%)
Krsnaa Diagnostics Ltd.
573.75
-1.05 (0.18%)
Shalby Ltd.
157.28
-4.39 (2.72%)
Fermenta Biotech Ltd.
473.65
-10.20 (2.11%)
Amrutanjan Health Care Ltd.
488.35
-45.40 (8.51%)
Jagsonpal Pharmaceuticals Ltd.
225.47
-5.52 (2.39%)
Suraksha Diagnostic Ltd.
270.35
12.10 (4.69%)
Syncom Formulations (India) Ltd.
15.88
1.35 (9.29%)
Windlas Biotech FAQs
The Buying Price of Windlas Biotech share is 894.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Windlas Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Windlas Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Windlas Biotech shares is 29.29. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Windlas Biotech shares is 3.79. Useful to assess the stock's value relative to its book value.
To assess Windlas Biotech’s valuation compare Sector P/E, P/B which are 65.02 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Windlas Biotech is 1846.32 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Windlas Biotech share price is 1097.90 & 697.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Windlas Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
